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Abstract
Objective: Exposure to repetitive concussion, or mild traumatic brain injury
(mTBI), has been linked with increased risk of long-term neurodegenerative
changes, specifically chronic traumatic encephalopathy (CTE). To date, preclinical
studies largely have focused on the immediate aftermath of mTBI, with no litera-
ture on the lifelong consequences of mTBI in these models. This study provides
the first account of lifelong neurobehavioral and histological consequences of
repetitive mTBI providing unique insight into the constellation of evolving and
ongoing pathologies with late survival. Methods: Male C57BL/6J mice (aged 2–
3 months) were exposed to either single or repetitive mild TBI or sham proce-
dure. Thereafter, animals were monitored and assessed at 24 months post last
injury for measures of motor coordination, learning deficits, cognitive function,
and anxiety-like behavior prior to euthanasia and preparation of the brains for
detailed neuropathological and protein biochemical studies. Results: At
24 months survival animals exposed to r-mTBI showed clear evidence of learning
and working memory impairment with a lack of spatial memory and vestibule-
motor vestibulomotor deficits compared to sham animals. Associated with these
late behavioral deficits there was evidence of ongoing axonal degeneration and
neuroinflammation in subcortical white matter tracts. Notably, these changes
were also observed after a single mTBI, albeit to a lesser degree than repetitive
mTBI. Interpretation: In this context, our current data demonstrate, for the first
time, that rather than an acute, time limited event, mild TBI can precipitate a life-
long degenerative process. These data therefore suggest that successful treatment
strategies should consider both the acute and chronic nature of mTBI.
Introduction
Mild traumatic brain injury (mTBI) has been called a
“silent epidemic” as the initial symptoms can be so subtle
that the majority of people who have experienced a con-
cussion do not seek medical attention.1,2 As a result, the
consequences of repeated concussions/mTBI (r-mTBI)
have long been underestimated and viewed as a transient
injury without long-term consequences. However, a subset
of this population demonstrates persisting neurocognitive
dysfunction and non-neurological disorders that cannot
be considered mild.3 Notably, it is now well documented
that the adverse effects of r-mTBI in participants of con-
tact sports and in former military personnel may continue
for many years after the original event,4–8 with brain
trauma being a risk factor for the development of
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neurodegenerative disease,9 in particular chronic traumatic
encephalopathy (CTE); for review see Smith et al.10
Despite increasing evidence that mTBI is associated with
late neurodegenerative pathologies,11,12 there is limited
understanding of the processes linking an acute phase
biomechanical injury to late and progressive neurodegen-
erative pathologies. In particular, current models of TBI
are largely limited to acute phase studies or, where data
with survival are reported, this rarely extends beyond
12 months. Nevertheless, in those few models exploring
“late” survival there is notable evidence that early injury
can have persisting and evolving consequences, even at a
year post -injury including: chronic neuroinflammation,13–
15 ongoing axonal degeneration and white matter atrophy,13
cerebrovascular abnormality,16 deposition of abnormal tau
in transgenic animals,15,17,18 and neurobehavioral impair-
ments.13 However, despite growing evidence that the conse-
quences of r-mTBI might be regarded as a “lifetime illness,”
to date, existing animal models arguably have failed to pro-
vide an accurate surrogate of events in human TBI survival
across a lifetime. To address this, we hereby present behav-
ioral, neuropathological and biochemical analyses
24 months after a single mTBI (s-mTBI) or r-mTBI in a val-
idated rodent model of closed head mild TBI.
Materials and Methods
Animals
Male, C57BL/6J mice (aged 2–3 months old, 32–42 g,
Jackson Laboratories, Bar Harbor ME) were housed singly
under standard laboratory conditions (23  1°C,
50  5% humidity, and 12-h light/dark cycle) with free
access to food and water throughout the study until their
euthanasia at age 27 months. All procedures were carried
out under Institutional Animal Care and Use Committee
approval and in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory Animals.
Injury groups and schedule
Animals were subjected to closed head mild TBI or anes-
thetic as sham as previously described.13,19 For the behav-
ioral analyses, a total of 32 mice were randomly assigned to
one of four groups: single injury, single sham (anesthesia
alone), repetitive injury (total of five hits with an intercon-
cussion interval of 48 h), and repetitive sham (five anesthe-
sias, 48 h apart). The behavior analysis began 2 years after
the sole/last mTBI/anesthesia for each group. By the time
of testing, one mouse assigned to r-sham, and one assigned
to s-mTBI had died of natural causes, and further, a
r-mTBI mouse was excluded from behavioral analysis due
to severe dermatitis; thus the final numbers were s-sham
(8), r-sham (7), s-mTBI (7), and r-mTBI (7). Of these,
tissue from three mice per group were assigned for bio-
chemical analyses, whereas the remaining (4–5 per group)
were processed for histological examination.
Injury protocol
The mTBI was administered to mice as previously
described.19 Mice were anesthetized with 1.5 L/min of
oxygen and 3% isoflurane prior to anesthesia or mTBI.
The animals were placed on a heating pad to maintain
their body temperature at 37°C. A 5 mm blunt metal
impactor tip was retracted and positioned midway along
the sagittal suture before each impact. The injury was trig-
gered using the myNeuroLab controller at a strike velocity
of 5 m/sec, strike depth of 1.0 mm, and dwell time of
200 msec. Our criteria for a mild injury were as follows:
(1) a short period of posttraumatic apnea <30 sec (rec-
ognized as an animal analog to human loss of conscious-
ness,20 (2) a short period of righting reflex <6 min, (3) no
sign of skull fractures and (4) no history of major hemor-
rhage(s) at the time of euthanasia. Moreover, our interin-
jury interval was 48 h, which is similar to our previous
work,13,19 a temporal window during which the mouse
brain is known to be vulnerable to subsequent injuries21 in
order to mimic human situations (combat or sports) in
which additional injuries are sustained prior to full recov-
ery from the previous injury. At the end of the procedure,
each animal was removed from the stereotaxic table and
allowed to recover on a heating pad and, upon becoming
ambulatory, was returned to its home cage. R-mTBI mice
received a total of five hits, with a 48 h interinjury interval.
Sham-injured animals underwent the same procedures and
were exposed to anesthesia for the same length of time as
the mTBI animals, but did not receive a hit, in order to
control for the effects of single or repeated anesthesia.
Assessment of motor function
The rotarod apparatus (Ugo Basile, Varese, Italy) was used
to assess motor performance by measuring the latency to
remain on an elevated accelerating rod as previously
described.19 The device was set to accelerate from 5 to 50
rotations per minute during a period of 5 min. For each
trial, latency to fall was timed by an experimenter blinded
to group assignment. The trial was also terminated if the
animal spun around the rod through three complete revo-
lutions. This trial was repeated three times per day for a
period of 5 days, with an intertrial interval of 5 min, and
the researchers conducting the experiments were blinded
to the group assignment of the mice.
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Assessment of learning and cognitive
function
Cognitive function was evaluated at 24 months post-
injury/sham using the Barnes maze (BM) in the same man-
ner we described previously.13,19 Researchers conducting
the experiments were blind to mouse grouping, and the
Ethovision XT system (Noldus, Wageningen, NL) was used
to track and record the movement of each animal. Mice
were given 90 sec to locate and enter the target box, and
they were required to remain in the target box for 30 sec
prior to their retrieval, regardless of success. Escape latency
measured the time taken for the mouse to enter the box in
order to escape the brightly lit, open surface of the maze.
For a period of 6 days, four trials were given per day, with
mice starting from one of four cardinal points on each trial.
On the 7th day of testing, a probe trial was conducted in
which the target box was removed and the time spent to
reach the zone previously containing the box was recorded
over one 60 sec trial.
Assessment of anxiety
Anxiety-like behavior was assessed using an elevated plus
maze, which relies on the animal’s preference for dark
enclosed arms rather than brightly lit, open arms. This
task assesses the willingness of the mouse to explore the
open arms of the maze which are fully exposed and at an
elevated height. Time spent in the open arms is decreased
in mice that exhibit anxiety-like behaviors. The maze con-
sisted of a polyvinyl chloride plus-shaped platform ele-
vated 50 cm from the floor with four arms intersecting at
a 90° angle, creating four individual arms each 55 cm
long and 5 cm wide. Closed and open arms were orthog-
onal to each other; the two closed arms were shielded by
25 cm high side and end walls, whereas the two open
arms had no walls. The experimental procedure was initi-
ated by the placement of the mouse into the center zone
(intersection point) of the maze, facing one of the open
arms. The mouse was allowed to explore the maze for a
5-min period while an overhead video camera recorded
the movements of each mouse. Ethovision XT was used
to automatically score, in an unbiased manner, the num-
ber of entries in each of the arms. All four paws of the
mouse had to enter an arm for it to be considered an
entry, and the percentage score for the time spent in the
open arm was calculated as follows: (time spent in the
open arms/[time spent in the open arms + time spent in
closed arms]) 9 100.
Histology
At 24 months post-mTBI/sham injury, mice assigned to
histological studies were anesthetized with isoflurane and
perfused transcardially with phosphate-buffered saline
(PBS), pH 7.4 followed by PBS containing 4%
paraformaldehyde. After perfusion, the brains were post-
fixed in a solution of 4% paraformaldehyde at 4°C for
48 h. The intact brains were then blocked and processed
as previously described.19 For each group, sets of sagittal
sections (lateral 0.2–0.4 mm) were cut. Sections were
stained with Luxol fast blue/cresyl violet (LFB/CV) using
standard histological protocols. Sets of adjacent sections
were stained with a panel of antibodies (Table 1) for
immunohistochemical analyses. Each slide was visualized
with a bright field microscope (BX60), and digital images
were visualized and acquired using an Olympus Magna-
Fire SP camera.
Immunohistochemical quantification
For each animal, sagittal sections were stained and ana-
lyzed by an observer blinded to experimental conditions
using ImageJ software (US National Institutes of Health,
Bethesda, MD, USA). Using this software, images were
separated into individual color channels (hematoxylin
Table 1. Summary of antibodies used in this study.
Protein target Antibody Epitope IHC-Dilution Source Assay
Amyloid precursor protein 22C11 aa 66–81 1:40,000 Millipore IHC
Glial fibrillary acidic protein GFAP GFAP 1:20,000 Dako IHC
Iba-1 Iba-1 Iba-1 1:5000 Abcam IHC
Leukocyte common antigen CD45 CD45 (mca1388) 1:1000 Biorad IHC
Total-tau (mouse) DA9 aa 102–140 1:1000 Dr. P. Davies Dot blot
Total-tau (mouse) DA31 aa 150–190 N/A Dr. P. Davies ELISA/WB
Phospho-tau (mouse) CP13 pS202 1:400 Dr. P. Davies ELISA/IHC/WB
Phospho-tau (mouse) PHF1 pS396/404 1:400 Dr. P. Davies ELISA/IHC/WB
Phospho-tau (mouse) RZ3 pT231 1:400 Dr. P. Davies ELISA/IHC/WB
Phospho-tau (mouse) MC1 Conformational 1:200 Dr. P. Davies IHC
Beta amyloid (Ab) 4G8 aa 17–24 1:750 Covance IHC
aa, amino acid; IHC, Immunohistochemistry; ELISA, enzyme-linked immuno-sorbent assay; WB, western blot.
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counter stain and DAB) using the color deconvolution
algorithm.22 Three nonoverlapping areas of 100 lm2 for
the body of the corpus callosum (CC) were randomly
selected, within which the area of glial fibrillary acidic
protein (GFAP) immunoreactivity was calculated and
expressed as a percentage of the field of view (lateral 0.2–
0.4 mm). Four nonoverlapping areas of 150 lm2 between
layer III and IV in the primary somatosensory cortex, and
three nonoverlapping areas of 100 lm2 in the CC were
randomly selected within which the area of anti-Iba1
immunoreactivity was calculated and expressed as a per-
centage of the field of view (lateral 0.2–0.4 mm). The
extent of axonal injury was determined in APP-stained
sections. APP immunoreactive axonal swellings were
quantified from the caudal to the dorsal area of the body
of the CC. Using ImageJ software, the average thickness
of the corpus callosum was calculated as previously
described.13 A total of five slides per animal were aver-
aged for each immunohistochemical analysis.
Quantitative assessment of soluble Ab40,
phosphorylated tau, and total tau protein
Analyses of soluble Ab40, phosphorylated tau and total
tau protein were carried out on cortical and hippocampal
brain regions obtained from PBS-perfused mice at
24 months post-s/r-mTBI (n = 3/group) or s/r-sham
exposure (n = 3/group). Snap-frozen dissected cortices
and hippocampi were sonicated in 0.5 mL and 0.3 mL of
chilled M-PER buffer solution (Thermo Fisher Scientific,
Waltham, MA) supplemented with a protease and phos-
phatase inhibitor cocktail (Thermo Fisher Scientific, Wal-
tham, MA). Soluble Ab40 was assessed using a sandwich
ELISA (WAKO, Richmond, VA) as per the manufac-
turer’s directions. For tau biochemistry, tissue homoge-
nates were coded and sent to Dr. Peter Davies’ group at
the Feinstein Institute for Medical Research (Manhasset,
NY), for blinded quantitative assessments. Sample prepa-
ration for the low-tau sandwich ELISA and quantitation
of murine-specific tau protein was performed as previ-
ously described.23 Antibodies to detect total and phospho
tau (Table 1) were used as capture antibodies in the low-
tau, Sandwich ELISA. Total protein content was deter-
mined by the bicinchonic acid (BCA) method (Thermo
Scientific, Waltham, MA) and data were expressed as
pmol/g protein (Ab40) and ng tau/mg protein (tau and
phosphorylated tau).
Dot blot analyses of total tau in plasma
samples
At euthanasia, anesthetized mice were exsanguinated via
aortic puncture using a wide-bore needle to prevent
hemolysis of red blood cells. Blood samples were collected
into a 1.6-mL Eppendorf tube containing EDTA and sup-
plemented with a protease inhibitor cocktail (PIC) (Roche
Diagnostics Corporation, Indianapolis, IN) to a final con-
centration of 1X. Samples were cooled on ice for up to
1 min prior to centrifugation at room temperature at
3000 g for 3 min to minimize platelet coagulation. Fol-
lowing separation, clarified plasma was transferred to a
clean Eppendorf tube and snap-frozen in liquid nitrogen.
Following a brief vortexing, 3 lL of each sample was
spotted directly onto nitrocellulose membranes (Biorad,
CA, USA). Membranes were blocked for 1 h at room
temperature in 10% nonfat dry milk dissolved in Tris-
buffered saline (Biorad, CA, USA) and incubated with the
primary antibody total tau DA9 overnight at 4°C. After
the hybridization, membranes were rinsed in distilled
water for 30 min and incubated for 2 h at room tempera-
ture with secondary anti-mouse antibody conjugated with
peroxidase (Cell Signaling technology, MA, USA). Signal
detection and quantification were performed with a two-
fold dilution of the SuperSignal west femto maximum
sensitivity chemiluminescent substrate (Thermo Scientific,
IL, USA) by chemiluminescence imaging with the Chemi-
DocTM XRS (Bio-Rad, CA, USA). After hybridization
with the primary antibodies, all membranes were stained
for 30 min with a Fast Green solution which was used to
adjust for variation in protein amounts spotted onto
nitrocellulose membranes. All results were expressed as a
ratio of DA9/Fast Green signals.
Statistical analysis
All behavioral and pathological data were analyzed using
JMP 8.0 (SAS, Cary, NC). Scores were analyzed separately
for groups of animals assigned to survival groups at
24 months post-injury. Data were tested for normality
using the Shapiro–Wilk W test; when not normally dis-
tributed, the data were transformed using square root or
natural log transformation. If the data were still not nor-
mal after transformation, nonparametric methods were
used for analysis. Repeated-measures ANOVA was used
to compare performance during the 6 days of acquisition
of the Barnes maze between the matching injury groups
when the data were normally distributed. Repeated-mea-
sures ANOVA was also used to compare the pathological
quantifications and behavior performances during the five
time points of acquisition during the life of the animal
between the matching injury groups. Potential sphericity
violations were corrected by adjusting degrees of freedom
for all repeated-measures effects using the Greenhouse-
Geisser estimate for epsilon. The Barnes Maze Probe
dataset and quantitative histologic parameters were ana-
lyzed with one-way ANOVA, with a Tukey’s post hoc
ª 2017 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. 67
B. C. Mouzon et al. Lifelong Consequences of Repetitive Mild TBI
correction for multiple comparisons, unless otherwise
indicated. Behavior, pathological, and ELISA data were
plotted and analyzed using Graph-Pad Prism (Prism 6.01,
GraphPad Software Inc, La Jolla, CA). One-way ANOVA
followed by Tukey’s post hoc test was used for compar-
ison of soluble tau and Ab40 levels between the four
groups. Only P values <0.05 were considered to be statis-
tically significant and are indicated by an asterisk in the
figures. Error bars represent the standard error of the
mean (SEM).
Results
mTBI is associated with persistent and long-
term learning deficits
At 24 months post-last injury, both s-mTBI and r-mTBI
mice travelled a longer distance to reach the target box in
the Barnes maze when compared with their respective
shams, (r-mTBI vs. r-sham, P < 0.0001; s-mTBI vs.
s-sham, P < 0.05; repeated-measures ANOVA) (Fig. 1A)
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Figure 1. Assessment of neurobehavioral change at 24 months post-mTBI. (A) Learning deficits were evaluated during the 6 days of acquisition.
Both injured groups traveled a greater distance before escaping to the target hole compared to their respective anesthesia controls (s-sham vs.
s-mTBI, *P < 0.05; r-sham vs. r-mTBI and s-mTBI vs. r-mTBI, ***P < 0.0001; repeated-measures ANOVA). At all-time points, the performance of
the r-mTBI group was worse than that of the s-mTBI group (s-mTBI vs. r-mTBI, ***P < 0.0001; repeated-measures ANOVA). (B) Both injured
groups fail escaping to the target hole when compared with their sham controls at every single day of training; Wilcoxon signed rank test,
***P < 0.0001. (C) The spatial memory test (probe) showed no difference across each group. However, there was a trend for the
r-mTBI mice to take longer to reach the target zone indicating a possible deficit of spatial memory. Data are presented as mean  SEM, one-way
analysis of variance with Tukey’s post hoc test; P > 0.05; each symbol represents 1 mouse. (D) Risk-like behavior measuring the willingness of the
animal to explore exposed arm at a specific height was assessed using an elevated plus maze. The r-mTBI mice developed an increased risk taking
behavior by spending more time in the open arms of the elevated plus maze when compared with control mice, one-way analysis of variance
with Tukey’s post hoc test; *P < 0.01; **P < 0.001. Values represent mean  SEM (n = 7 per group).
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suggesting an impairment of visuospatial learning. A defi-
cit in performance was also apparent comparing the
r-mTBI group to the s-mTBI group (r-mTBI vs. s-mTBI,
P < 0.0001; repeated-measures ANOVA). Performance of
the r-sham group was similar to the s-mTBI (r-sham vs.
s-mTBI, P > 0.05; repeated-measures ANOVA). Conse-
quently, the average distances travelled by the r-mTBI
and the s-mTBI mice over the 6 days acquisition period
were 38%, and 45% longer than their respective sham
controls. The performance of these animals was directly
related to the number of injuries they received.
The dataset for latency to escape was not normally dis-
tributed and thus did not satisfy the assumptions required
for a repeated-measure ANOVA. The Wilcoxon signed
rank test was used to test for the daily correlation
between each group. The mean escape latency of the
s-mTBI and the r-mTBI did not improve between their
first and last acquisition day (s-mTBI 81.4  2.6 sec on
day 1 to 88.7  4.4 sec on day 6; r-mTBI 89.1  2.8 sec
on day 1 to 89.9  4.1 sec on day 6). Over the 90 sec
trial period all the animals found the target hole but
almost none of them made the decision to enter into the
escape box. Consequently, no difference in escape latency
performance was observed between the s-sham vs. r-sham
and s-mTBI vs. r-mTBI (day 1–6 of acquisition; P > 0.05)
(Fig. 1B). Overall, both sham groups could find the hid-
den box with similar latencies (on average 74 sec) to
escape the maze while both injured groups did not reach
the hidden box on the table at every single day of training
(Wilcoxon signed rank test, ***P < 0.0001).
No TBI-dependent spatial memory deficits
were observed at 24 months post-mTBI
Probe test performance (defined as the latency to reach
either the target hole or the holes immediately adjacent to
the target hole) revealed that the r-mTBI mice performed
the worst, requiring on average 36 sec to reach the target
zone, followed by the r-sham (33 sec), the s-mTBI (31 sec),
and the s-sham (18 sec) (P > 0.05 as determined by one-
way ANOVA followed by Tukey’s post hoc test) (Fig. 1C).
The mean velocity for the probe trial was similar across all
groups (P > 0.05; data not shown). The performance of
each group had declined progressively since they were last
tested at 21 months of age (18 months post-injury/anes-
thesia), however, early life r-mTBI did not significantly
worsen spatial memory deficits in these aged animals.
mTBI was not associated with late
vestibulo-motor deficits
Following evaluation in the Barnes maze at 24 months post-
injury/anesthesia, motor performance for each group was
tested with the rotarod. Overall, the performance of singly or
repetitively injured animals was not different from controls,
supporting the transient nature of the motor deficits detected
acutely post-injury, as previously reported.13,19 The results
from day 1 of pretraining compared to the last day of rotarod
were as follows: s-sham 99.2  8.5 sec vs. 136.0  6.1 sec;
s-mTBI 82.1  6.9 sec vs. 128.2  10.8 sec; r-sham
78.0  6.6 sec vs. 125.8  11.1 sec; r-mTBI 82.7  6.8 sec
vs. 137.1  12.5 sec.
r-mTBI causes increased risk behavior/
disinhibition at 24 months post-mTBI
To characterize the long-term effects of single or
repetitive mild TBI on anxiety-related behaviors, the
exploratory activity of each animal was tested in the ele-
vated plus maze (Fig. 1D). While there was no differ-
ence in the percentage of time spent in the open arms
between the s-mTBI and either of the control groups (s-
sham, 9.9 2.7%; r-sham, 6.1  2.1; s-mTBI,
14.1  4.3%; P > 0.05 one-way ANOVA followed by
Tukey’s post hoc test), the r-mTBI group spent on aver-
age 30.18.3% of their time within the open arm (s-
sham or s-mTBI, vs. r-mTBI P < 0.05; r-sham vs. r-
mTBI, P < 0.001; one way ANOVA followed by Tukey’s
post hoc test). Such an increased amount of time spent
in the open arms is suggestive of disinhibition or
increased risk-taking behavior which has been previously
observed in other mouse models of repetitive closed
head injury.14,24
mTBI is associated with ongoing axonal
degeneration and thinning of the corpus
callosum
Changes in white matter integrity and thickness of the
body of the corpus callosum were assessed in sections
stained for LFB/CV. At 24 months following s-mTBI,
there was a 26% reduction in thickness of the body of the
CC compared to s-sham (P < 0.001; one way ANOVA
followed by Tukey’s post hoc test) (Fig. 2G). Similarly,
the r-mTBI animals showed thinning of the body of the
CC, with a decrease of 29% (P < 0.001; one-way ANOVA
followed by Tukey’s post hoc test) when compared with
the r-sham group.
At 24 months post-injury, APP-immunoreactive pro-
files were scattered diffusely throughout the corpus cal-
losum in all groups, injured and sham. Typically, these
were observed as sparse, rounded to granular
immunoreactive axonal profiles (Fig. 3D). The differ-
ence in the number of APP-immunoreactive profiles
observed was greatest in the r-mTBI versus r-sham com-
parison (r-mTBI 8.5  1.4 vs. r-sham 3.6  1.2 axonal
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profiles/body of CC; P < 0.001), with the s-mTBI/sham
comparison not reaching significance (s-mTBI
4.6  1.1, s-sham 2.8  0.2 axonal profiles/body of
CC).
mTBI induces persisting astrogliosis in the
corpus callosum
For all groups, the cortical region underlying the impact site
(somatosensory and primary motor cortices) and the CC
Figure 2. LFB/CV staining indicated changes in white matter integrity in the injured animals at 24 months post-injury. (A-D) Reduction in the CC
thickness at 24 months post r-mTBI. Scale bar, 200 lm. (G) At 24 months, the thickness of the CC was decreased on average by 26% after
s-mTBI, and by 29% in the r-mTBI. (E, F) Higher power view of the r-sham and r-mTBI. Scale bar, 20 lm The CC thickness was measured with
ImageJ by averaging 6 measurements for each hemisphere per mouse. Each symbol represents the average of both hemispheres. Data are
presented as mean  SEM, one-way ANOVA with Tukey’s post hoc test was used for comparison of each group; **P < 0.001.
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were assessed in sections stained for GFAP. No TBI-depen-
dent quantitative difference in the level of GFAP immunopos-
itivity was detected in the cortices (s-sham 1.4  0.3%; s-
mTBI 1.7  0.1%; r-sham 1.1  0.3%; r-mTBI 1.6  0.4%;
P > 0.05; Fig. 4). However, in the CC, the r-mTBI (Fig. 4) and
s-mTBI groups showed a notable increase in the area of GFAP
immunoreactivity compared with their respective sham con-
trols (Fig. 4E–H), with the magnitude of this increase being
greater in the r-mTBI than in the s-mTBI group (s-mTBI
24.2  1.6% vs. s-sham 15.3  2.1%; P > 0.05; r-mTBI
27.4  2.7% vs. r-sham 15.8  2.5%; P < 0.01; Fig. 4I).
mTBI induces persisting neuroinflammation
in the corpus callosum
To gain insight into whether a single mTBI or r-mTBI
could accelerate or sustain the degree of inflammation in
aged animals, we investigated two different markers of
brain inflammation, Iba-1, a marker of microglia and
CD-45, a cell surface marker of monocytes/lymphocytes.
In the retrosplenial, sensorifrontal, and motor cortex,
there was no appreciable evidence of microglial activation
for any group at 24 months post-injury (Fig. 5E–H, J).
The morphological characteristics of the microglial cells
were relatively similar across each group, with a primed
morphology characteristic of an aged mouse brain.
In contrast, in the body of the corpus callosum, the
r-mTBI showed a notable increase in anti-Iba1 reactivity
(Iba1: r-mTBI 14.7  1.3% vs. r-sham 10.7  1.5%
P < 0.05) (Fig. 5A–D, I). A slight but noticeable increase
in both Iba-1 and CD45+ immunoreactivity was observed
in the s-mTBI group compared to controls; however, this
was not significant (P > 0.05 for either marker).
mTBI is not associated with increased Ab40
or tau phosphorylation
Immunohistochemical assessment revealed no injury effect
on the localization or accumulation of the p-tau epitopes
CP13, (Fig. 6A), PHF1 and RZ3 (data not shown). All exper-
imental groups exhibited somatodendritic accumulation of
CP13 immunoreactivity in neurons of the superficial layer of
the cerebral cortex, and in the CA1 and CA3 regions of the
hippocampus. The same brain regions were devoid of PHF1-
Figure 3. Immunohistochemical labeling for amyloid precursor protein at 24 months post-injury. (A-D) Sagittal sections of the mouse brain
approximately 0.2 mm lateral to midline in the corpus callosum. A few axonal profiles were observed in the CC of the sham groups and the
s-mTBI. Scale bar, 50 lm. (D) There was an increase in accumulation of discrete axonal profiles in the CC in the r-mTBI compared to their sham
counterpart; *P < 0.01. Tissue sections were counterstained with hematoxylin. (E) Quantitative analysis of APP staining within the body of the CC;
each symbol represents 1 mouse. Data are presented as mean  SEM, one-way analysis of variance with Tukey’s post hoc test was used for
comparison of each group; *P < 0.01, **P < 0.001.
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and MC1-positive neurons regardless of the injury status
(data not shown). Consistent with our previous observation
of lack of increased Ab40 or tau phosphorylation at
12 months post single and r-mTBI/anesthesia,13 the analysis
of Low-Tau ELISAs at the 24 month time point showed no
TBI-dependent increase in cortical or hippocampal soluble
p-tau pSer-202 (CP13), pThr-231 (RZ3), and pSer-396/404
(PHF1) (P > 0.05) (Fig. 6D). Phospho-tau was also quanti-
tated as a ratio of phosphorylated tau protein to total tau
protein; however, there was no injury effect on these ratios
in either brain region (cortex; hippocampus) (Fig. 6D).
Changes in the plasma level of total tau have been
reported in other neurodegenerative diseases. Therefore we
employed a dotblot approach established by Paris et al.25
to quantify total tau (DA9) concentration in plasma sam-
ples at the time of euthanasia. However, no association was
revealed between r-mTBI and an accumulation of tau pro-
tein in plasma samples of aged animals (Fig. 6B and C).
ELISA analysis of soluble murine Ab40 showed no TBI
or age-dependent increases (data not shown). Ab deposi-
tion assessed by the 4G8 antibody or Congo Red staining
(data not shown) was not detected in the cerebral cortex
Figure 4. Repetitive mTBI increases astrogliosis in the corpus callosum at 24 months post-injury. Sagittal sections of the mouse brain approximately
0.2 mm lateral to midline in (A–D) the layer III/IV of the cortex and (E–H) in CC with GFAP. Scale bar, 50 lm and 100 lm, respectively. (I)
Quantitative analysis of GFAP staining revealed extensive GFAP immunoreactivity within the CC of the r-mTBI group compared to both sham
groups; *P < 0.05. (J) There was no difference in the expression of GFAP within the cortex of the injured animals compared to their sham
counterparts. Tissue sections were counterstained with hematoxylin. (I, J) Quantitative analysis of GFAP staining in three 100 lm2 fields within the
body of the CC and four 200 lm2 fields between layer III and V of the cortex at 24 months post-injury; each symbol represents 1 mouse. Data are
presented as mean  SEM, one-way analysis of variance with Tukey’s post hoc test was used for comparison of each group; *P < 0.05.
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or in the hippocampus of any group at 24 months post-
injury.
Lifelong consequence of mTBI
To evaluate the changes presented in this study in the
context of lifelong exposure to mTBI, data common to
both our two previous manuscripts (detailing outcomes
in mice 24 h to 18 months post injury) were re-examined
along with the 24 months post injury data presented
herein (Fig. 7). Collectively, our datasets demonstrate that
a history of single or repetitive mTBI experienced early in
life alters the neurobehavioral and neuropathological phe-
notype of animals across the lifespan.
Regarding behavioral outcomes, we observed that single
or repetitive mTBI produced irreversible impairment in
performance as early as 21 days post-injury. For all
groups, the overall performance was steady and improved
Figure 5. Repetitive mTBI induces persisting neuroinflammation in the corpus callosum at 24 months post-injury. (A-D) Sagittal sections of the
mouse brain approximately 0.2 mm lateral to midline in the layer III/IV of the cortex labeled with the microglia marker Iba-1. (E–H) Sagittal
sections of the mouse brain approximately 0.2 mm lateral to midline in the body of the CC with the microglia marker Iba-1. (I) There was no
difference in the expression of Iba-1 within the cortex of the injured animals compared to their sham counterparts. Quantitative analysis of Iba-1
staining in four 150 lm2 fields between layer III and V of the cortex. (J) Quantitative analysis of Iba-1 staining in the CC was increased in the
r-mTBI compared to their sham counterpart; *P < 0.05. Quantitative analysis of Iba-1 staining in three 100 lm2 fields within the body of the CC.
Each symbol represents 1 mouse. Data are presented as mean  SEM, one-way analysis of variance with Tukey’s post hoc test was used for
comparison of each group; *P < 0.05.
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for the first 15 months post-mTBI before gradually
declining at the final timepoint of our behavioral assess-
ment (24 months after last injury). The performance of
these animals was directly related to the number of inju-
ries administered. When gathering evidence from all time
points examined, the s-mTBI and s-sham groups
Figure 6. Biochemical and immunohistochemical assessment of p-tau pSer-202 (CP13) in the neocortex and hippocampus at 24 months after
injury. (A) There was no TBI-dependent increase in cortical and hippocampal soluble CP13. All experimental groups exhibited somatodendritic
localized accumulation of CP13 immunoreactivity in neurons of the superficial layer of the cerebral cortex. Top right inset represents a
positive control animal (10 month-old P301S for CP13). (B) Representative dot-blots revealing the amount of DA31 (aa 150–190) in mouse
plasma samples at 24 months post-injury. (C) Protein content in each sample was normalized using fast green (FG) quantification. The scatter
plot represents the average DA31/FG, chemiluminescent signals quantified in mouse plasma samples. No statistical difference was observed
between any of the groups (P > 0.05). (D) Quantitative assessment of tau immunohistochemistry revealed no change between sham and
injured animals in all groups. Similar to the quantitative analysis of each p-tau epitope, there was no increase in pThr-231 (RZ3), and pSer-
396/404 (PHF1) when quantitated as a ratio of p-tau protein to total tau protein. Each symbol represents 1 mouse. Data are presented as
mean  SEM, one-way ANOVA with Tukey’s post hoc test was used for comparison of each group; P > 0.05.
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performed similarly, with an exception at the acute time-
point, suggesting that all the animals recovered to their
baseline within a few weeks. However, when tested at
18 months or 24 months post-injury, their performances
were found to deteriorate at a faster rate than their sham
counterparts, suggesting that the consequences of a single
mild TBI may reappear in the context of normal aging at
late timepoints.
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Figure 7. Association of the chronic effects of single mTBI (black line), r-mTBI (red line) and normal aging (sham animal, blue line) on
neurobehavioral and neuropathological abnormalities in the body of the corpus callosum: a hypothesis based on different times the animals were
sacrificed. The temporal time course of Iba-1, GFAP and APP were plotted based on the values collected at 24 h, 3, 6, 12, and 24 months post
injury (stars). The neurobehavioral effects of mTBI were plotted based on data collected at 24 h, 6, 12, 18, and 24 months post injury. The
course of pathology between each time point is purely speculative and may not be representative of the actual behavioral/pathology relationship.
Similarly, single and r-mTBI triggered diffuse white matter pathology, with respect to axons showing immunopositivity for APP, astrocytic gliosis,
and microgliosis. The phenotype of these features was influenced by the frequency of the injuries. Compared to sham-injured mice, brain-injured
mice exhibited lifelong learning deficits and cellular abnormalities characterized by ongoing microgliosis and a low level of axonal damage in the
corpus callosum (s-mTBI vs. s-sham, *P < 0.05; repeated-measures ANOVA). In contrast, animals exposed to r-mTBI displayed a slower rate of
learning and exacerbated deficits in behavioral performance (r-mTBI vs. s-sham, ***P < 0.0001; repeated-measures ANOVA). These deficits arise
in parallel with a number of neuropathological abnormalities, including progressive neuroinflammation and axonal damage in the corpus callosum
(r-mTBI vs. s-sham, ***P < 0.0001; repeated-measures ANOVA). In this mouse model, neither a single nor a r-mTBI support an accelerated
accumulation of pathology as the animal aged, but rather a shift in increased pathology which progressed at the same rate as the sham animals
as they aged. It is interesting to speculate that additional head injuries at later time points in the life of the animal may potentially trigger a
stronger pathological response as the pathology has increased by both normal aging and a history of mTBI.
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Single and repetitive mTBI resulted in increased lifelong
microgliosis and astrocytosis in the corpus callosum, and
the extent of the neuropathological lesion was also depen-
dent on the frequency of the injuries (s-mTBI vs. s-sham,
*P < 0.05; r-mTBI vs. s-sham, ***P < 0.0001; repeated-
measures ANOVA). Our results suggest that mild TBI
initiates a neuroinflammatory milieu in brain regions sus-
ceptible to the type of injury received; with our model
being vulnerable to subcortical white matter lesions. When
compared with the previously reported earlier time points,
there was a noticeable age-related increase in astrogliosis
and microgliosis in the CC regardless of the group assign-
ment. Interestingly our study also suggests that while
repetitive mTBI induced a more robust microglial and
astroglial response in the corpus callosum but the pathol-
ogy was not exacerbated in the last few months of their
lifespan. However, mice who received a single injury expe-
rienced an accelerated decline between 15 and 27 months
that could possibly correlate with the decrease in cognitive
performance observed during the same period.
Although diffuse traumatic axonal injury has been
increasingly documented in studies acquired at autopsy
from patients in all severities of TBI, the question of
whether white mater pathology is a lifelong condition
remains to be established in humans. In our animal
model of mTBI, we previously reported ongoing axonal
injury that was accompanied by a thinning of the corpus
callosum at 12 months post-mTBI. We now can confirm
that white matter degradation and axonal degeneration is
a lifelong event in this model of r-mTBI.
Discussion
In this model of closed head injury, we have established the
first comprehensive profile of the chronic behavioral and
neuropathological consequences of single and repetitive
mild traumatic brain injury over the life span of the animal.
We found that both single and repetitive mTBI can have
deleterious effects on the neurobehavior of a mouse, albeit
at varying degrees. Animals demonstrated significant
improvement following injury, however, they never
returned to their control counterparts. Additionally, the
incipient hallmarks of injury typified by subtle to moderate
changes in spatial learning and memory, chronic neuroin-
flammation and ongoing axonal injury were still noticeable
even at 24 months after injury (see Summary in Table 2).
This study is one of the first to demonstrate that the effects
of mTBI do not simply disappear following injury, but
rather manifest subtly and progressively, with diminished
brain function over the lifetime of the animal.
Whereas most patients recover within a few days or weeks
after a concussion, a few individuals may develop long-last-
ing or progressively worsening symptoms because of the
repeated blows. Depending on the part of the brain affected,
the result can vary greatly across individuals. Repetitive
mTBI is clinically associated with symptoms of irritability,
impulsivity, aggression, depression, short-termmemory loss,
heightened suicidality, concentration difficulties, and sleep
disturbance.6 A recent series of studies have demonstrated
that cognitive deficits are more common in former athletes
who sustained sport concussions when compared with age-
matched control patients.26–30 This spectrum of behavioral
changes falls in line with our preclinical data implicating the
consequences of repetitive mTBI in the development of
chronic neurological sequelae. Collectively, with the results
of our previously published work,13,19 spatial learning per-
formance and executive function as measured by escape
latency and distance travelled for both s-mTBI and r-mTBI
groups was poorer than their respective controls, despite the
age-related decrease in performance observed across all
groups. These findings are consistent with observations in
the human population in which those suffering from repeti-
tive mTBI appear to also have cognitive deficits when com-
pared with healthy controls.28 Although there is no clinical
study to support this observation, our data also suggest that
the neurobehavior of the singly injured animals was normal
for most of their lives, but the last 6 months of their lifespan
saw rapidly diminishing cognitive performance. This study
brings a unique insight into the dynamics of behavioral out-
comes from a single mTBI in the context of the life of an ani-
mal. Nonetheless further research is required to validate our
observation.
In addition to learning and executive function impair-
ment, patients sustaining mTBI can develop behavioral
disinhibition or exhibit increased risk taking behavior.6,31
Table 2. Composite neurobehavioral and immunohistochemical
scores at 24 months post-mTBI/sham injury with sham group taken as
a baseline.
s-sham s-mTBI r-sham r-mTBI
Behavior tests
Vestibulo-motor deficit 0 0 0 0
Anxiety 0 x 0 xx
Spatial learning 0 x x xx
Spatial memory 0 x x xx
Pathological marker in the CC
Iba1-microgliosis 0 x 0 xx
GFAP-astrocytosis 0 x 0 xx
APP-axonal injury 0 x 0 xx
LFB-thinning of the CC 0 x 0 xx
Tau/amyloid 0 0 0 0
Total score 0 7 2 14
Mild (0), moderate (X), severe staining/impairment (XX). s-mTBI, single
mild traumatic brain injury; r-mTBI, repetitive mild traumatic brain
injury, s-sham, single sham; r-sham, repetitive sham; CC, Corpus Cal-
losum; LFB, luxol fast blue.
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The mice sustaining repetitive mTBI in this model
demonstrated behavioral disinhibition, as manifested in
the elevated plus maze at 24 months post injury. This
behavior was not observed in control mice and to a lesser
extent in the s-mTBI animals, suggesting the potential
deleterious, cumulative effect of repetitive mTBI.
Together, these observations fall in line with emerging
clinical data implicating repetitive mTBI and the develop-
ment of chronic neurological sequelae.
Interestingly, in the probe trial for the Barnes Maze,
which tested long-term retention of the learned target
box location, the performance of all groups declined shar-
ply when compared with the previous measurement as
they reach a more advance aged with the r-mTBI per-
forming the worst of all but without being significantly
different from their respective sham. One limitation of
this study is the low number of animals at the end of the
study. This lack of an effect may be the result of low
numbers of mice per group attributed partly to an aging
effect and attrition over the 2-year period of study. Some
animals were omitted because of death, frailty, or inactiv-
ity due to advanced aging. Such challenges are typically
encountered when advanced aging behavioral studies are
conducted. Like in the acquisition trials, while we
observed differences in cognitive performance between
injured and sham animals at 24 months post injury, their
performance was not exacerbated by a history of a single
or repetitive mTBI at 24 months post injury.
It remains controversial whether the hippocampus
plays a role in recognition memory during the probe trial,
with some studies showing that damage to the hippocam-
pus has little effect,32–34 whereas others show a correlation
with impaired performance.35–37 Because our model does
not show major neuropathological abnormalities in the
hippocampus apart from mild neuroinflammation, we
suggest that major alterations to the brain network caused
by axonal shearing in the corpus callosum (which con-
tains nerve fibers connecting one hemisphere to the
other) may contribute to disruptions in neuronal com-
munication, impaired cognitive processing and spatial
learning, thus driving the poor performance of the
r-mTBI animals. The effects of TBI on the normal syn-
chrony of neuronal networks and how it leads to cogni-
tive impairments are likely to be complex,38,39 and the
exact nature and timing of this network dysfunction in
our model remains to be elucidated. Nevertheless, our
observations are consistent with the findings from clinical
studies suggesting that r-mTBI associated with white mat-
ter changes has long-term implications for brain commu-
nication40 and cognitive functioning.41–44
From a neuropathological perspective, the 24-month
post injury data were consistent with our observations at
earlier timepoints.13,19 Mice exposed to repetitive injury
displayed evidence of ongoing microgliosis localized to
the CC. This was accompanied by white matter thinning
together with evidence of axonal degeneration, which
continued to progress from 12 to 24 months post injury.
In contrast, there was no evidence of ongoing white mat-
ter pathology in mice exposed to s-mTBI except for in
one animal. However, it must be pointed out that further
work is required to appreciate the full extent of axonal
injury as APP identifies only a population of axons. Our
paradigm is the first longitudinal animal study to show a
relationship between chronic neuroinflammation and
white matter degeneration in the corpus callosum without
focal TBI pathology (i.e., contusion, hematoma, etc). This
parallels the clinical findings that ongoing axonal injury is
a neuropathological feature after all severities of TBI.45–47
With evidence now coming from clinical studies and pre-
clinical models of mTBI, the potential for in vivo
biomarkers of neuroinflammation or white matter degra-
dation may be particularly important in providing
insights into mild TBI outcome and strategies for early
therapeutic intervention.
In the past decade, there have been several reports on
the effects of r-mTBI on amyloid b deposition6 and the
accumulation of the tau protein in very specific and recog-
nizable patterns following human brain trauma.4 In our
rodent mTBI model, we found no association between
r-mTBI and abnormal tau or Ab accumulation at
24 months post injury, mirroring our observations in ear-
lier timepoints. This is common to preclinical mTBI mod-
els, as mTBI-dependent tau pathology has been difficult to
model.48 This could be due to differences in injury mod-
els,49 injury severity,50 injury frequency,15 age51 at expo-
sure, species used (pig, rat, mice, gerbil), and genetic
background (e.g., whether the animal is expressing wild
type or human (or mutant) tau or amyloid). In a recent
review, we discussed the current literature and the difficul-
ties and challenges of developing in vivo TBI experimental
paradigms to explore the link between repetitive head
trauma with a focus on tau-dependent changes.48 No
agreement has yet been reached about the severity and
threshold of multiple traumatic brain injuries required to
initiate incipient tau or amyloid pathology in controlled
preclinical studies. More importantly, this study demon-
strates that neurodegenerative changes can occur in the
absence of tau or amyloid pathology, therefore suggesting
that Tau and amyloid aggregates are not the main driver
for the observed neurodegenerative process in this model
of mTBI. It also implies that treatments that target amy-
loid or Tau aggregates might not be the most effective in
rodents to treat the consequences of r-mTBI.
Taken together, the findings of our studies support the
hypothesis that TBI should be studied and treated, not
only as an acute event, but as a chronic health condition.
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In terms of treatment and rehabilitation, this also suggests
that the opportunities for therapeutic intervention in
those exposed to single or repetitive mTBI might not be
limited to acute time points but could extend throughout
the lifespan. The development and lifelong characteriza-
tion of this model, and the relevance of the neurobehav-
ioral and neuropathological outcomes to human TBI
patients provides a platform for therapeutic discovery and
exploration of treatment paradigms, including the efficacy
of late-stage and chronic treatment approaches such as
those recently demonstrated by Ferguson et al. 2016,52
which may be of relevance to the human mTBI popula-
tion.
Summary
In this model of closed head injury, we have established the
first comprehensive profile of the chronic behavioral and
neuropathological consequences of single and repetitive
mild traumatic brain injury over the life span of an animal.
Undoubtedly, the neurobehavioral and neuropathology of
survival from mTBI is complex and multifaceted. It is cru-
cial that TBI researchers and health organizations recognize
mTBI as a chronic health condition. In addition, new pub-
lic policies that affect access to rehabilitation services and
treatments over the life span must be promoted to address
the future management of mTBI. Overall, our current data
demonstrate for the first time that mild TBI can precipitate
a lifelong degenerative process.
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